Smartphone HIV Test
It is believed that an estimated 35.3 million people are living with HIV globally, with approximately 68% of new cases located in sub-Saharan Africa. It is a worrying fact that the majority of those a...
Rapid Legionella Test
Novarum™ has created a bespoke app and mobile testing solution for the world’s first on-site test for Legionella. This unique mobile test – delivered for Hydrosense – is now av...
Microbial Fuel Contamination Test
Requiring only a droplet of water in fuel to thrive, microbial growth has the potential to cause severe disruption. Aircraft and fuel storage tanks can be severely damaged or rendered out of operation...
Smartphone calprotectin test
First Calprotectin Home Test Kit In our latest case study we discuss how Novarum has worked closely with world-leading in-vitro diagnostic specialist, BÜHLMANN Laboratories AG, to develop the fir...
Choice & Flexibility
Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies.
Quality System Certification
Each site follows strict Quality Control and product release protocols, which coupled with effective Quality Assurance processes ensure our products meet stringent product quality, safety and customer requirements.
Innovation is at the heart of our operations. The extensive breadth and depth of our products and services portfolio is testimony to the ongoing investment in our people and facilities.
Experience & Trust
BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents.
The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.
Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.
Novarum™ technology transforms a smartphone into a diagnostic test reader, empowering users to read and share the results of rapid tests from the point of care. Our pioneering technology can be used by anyone, anywhere, with minimal training: connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.